Guidant's new stent approved in the US:
This article was originally published in Clinica
The FDA has approved Guidant's ACS Multi-Link Duet stent in the US. The stent, which is already sold internationally, is designed to be used in a wider range of vessel sizes than its predecessor, the ACS Multi-Link. Results from a non-randomised registry of 174 patients showed successful placement of the device in 99.4% of cases and six-month results are pending.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.